Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stroke

  Free Subscription

Articles published in
Heart
    June 2022
  1. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    >> Share

    April 2022
  2. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    >> Share

  3. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    >> Share

  4. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    >> Share

    March 2022
  5. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845
    >> Share

  6. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    >> Share

  7. BARBIELLINI AMIDEI C, Trevisan C, Dotto M, Ferroni E, et al
    Association of physical activity trajectories with major cardiovascular diseases in elderly people.
    Heart. 2022;108:360-366.
    >> Share

  8. WANG X, Dong JY, Cui R, Muraki I, et al
    Smoking cessation, weight gain and risk of cardiovascular disease.
    Heart. 2022;108:375-381.
    >> Share

    February 2022
  9. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    >> Share

  10. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.
    >> Share

    January 2022
  11. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.
    >> Share

    December 2021
  12. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.
    >> Share

  13. FRAISSE A, Hascoet S, Kempny A
    Closing atrial septal defects for prevention of stroke: how small is too small?
    Heart. 2021;107:1850-1851.
    >> Share

  14. DOLGNER SJ, Steinberg ZL, Jones TK, Reisman M, et al
    Stroke in patients with secundum atrial septal defect and sequelae after transcatheter closure.
    Heart. 2021;107:1875-1880.
    >> Share

    October 2021
  15. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    >> Share

  16. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    >> Share

  17. ARORA GK, Kumar Gupta P, Bansal S
    Transient ischaemic attack in a young woman.
    Heart. 2021;107:1629-1682.
    >> Share

    September 2021
  18. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    >> Share

    August 2021
  19. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    >> Share

  20. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    >> Share

    July 2021
  21. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    >> Share

  22. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    >> Share

    June 2021
  23. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    >> Share

  24. TAM DY, Rocha RV, Fang J, Ouzounian M, et al
    Multiple arterial coronary bypass grafting is associated with greater survival in women.
    Heart. 2021;107:888-894.
    >> Share

    May 2021
  25. DAGENAIS GR, Dyal L, Bosch JJ, Leong DP, et al
    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
    Heart. 2021 May 21. pii: heartjnl-2020-318758. doi: 10.1136/heartjnl-2020-318758
    >> Share

  26. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382
    >> Share

  27. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    >> Share

  28. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    >> Share

  29. PARK J, Yoon YE, Kim KM, Hwang IC, et al
    Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women.
    Heart. 2021 May 7. pii: heartjnl-2020-318764. doi: 10.1136/heartjnl-2020-318764.
    >> Share

  30. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.
    >> Share

  31. KARTHIKEYAN G
    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.
    >> Share

    April 2021
  32. BUCHAN TA, Malik A, Chan C, Chambers J, et al
    Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.
    Heart. 2021 Apr 8. pii: heartjnl-2021-319243. doi: 10.1136/heartjnl-2021-319243.
    >> Share

  33. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    >> Share

  34. SCOTT ML, Murnane KS, Orr AW
    Young at heart? Drugs of abuse cause early-onset cardiovascular disease in the young.
    Heart. 2021;107:604-606.
    >> Share

  35. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    >> Share

    March 2021
  36. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
    Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
    Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
    >> Share

  37. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    >> Share

    February 2021
  38. LOWRES N, Giskes K, Freedman B
    Next frontier in management of atrial fibrillation.
    Heart. 2021 Feb 23. pii: heartjnl-2021-318961. doi: 10.1136/heartjnl-2021-318961
    >> Share

    January 2021
  39. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    >> Share

  40. MALLINSON PAC, Luhar S, Williamson E, Barreto ML, et al
    Socioeconomic position and cardiovascular mortality in 63 million adults from Brazil.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318153. doi: 10.1136/heartjnl-2020-318153
    >> Share

  41. MARCUSCHAMER I, Zusman O, Iakobishvili Z, Assali AR, et al
    Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
    Heart. 2021 Jan 18. pii: heartjnl-2020-318047. doi: 10.1136/heartjnl-2020-318047
    >> Share

  42. MAZNYCZKA AM, McCartney P, Duklas P, McEntegart M, et al
    Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial.
    Heart. 2021 Jan 12. pii: heartjnl-2020-317828. doi: 10.1136/heartjnl-2020-317828
    >> Share

  43. VASCONCELOS M, Vasconcelos L, Ribeiro V, Campos C, et al
    Incidence and predictors of stroke in patients with rheumatic heart disease.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318054. doi: 10.1136/heartjnl-2020-318054.
    >> Share

  44. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    >> Share

  45. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.
    >> Share

  46. OTTO CM
    Heartbeat: increased use of NOACs in patients with atrial fibrillation reduces health care system costs by reducing stroke incidence.
    Heart. 2021;107:1-3.
    >> Share

    December 2020
  47. O' DONNELL M, Hankey GJ, Rangarajan S, Chin SL, et al
    Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level.
    Heart. 2020 Dec 14. pii: heartjnl-2019-316515. doi: 10.1136/heartjnl-2019-316515
    >> Share

  48. GARCIA RODRIGUEZ LA, Cea Soriano L, Munk Hald S, Hallas J, et al
    Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.
    Heart. 2020 Dec 11. pii: heartjnl-2020-317887. doi: 10.1136/heartjnl-2020-317887
    >> Share

  49. HANON O, Vidal JS, Pisica-Donose G, Orvoen G, et al
    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
    Heart. 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
    >> Share

    November 2020
  50. SANJOY S, Choi YH, Holmes D, Herrman H, et al
    Comorbidity burden in patients undergoing left atrial appendage closure.
    Heart. 2020 Nov 23. pii: heartjnl-2020-317741. doi: 10.1136/heartjnl-2020-317741
    >> Share

    October 2020
  51. SEIFFGE DJ, Meinel TR
    The real prize of direct oral anticoagulant blockbuster.
    Heart. 2020 Oct 28. pii: heartjnl-2020-318092. doi: 10.1136/heartjnl-2020-318092
    >> Share

  52. ORLOWSKI A, Gale CP, Ashton R, Petrungaro B, et al
    Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-317006. doi: 10.1136/heartjnl-2020-317006
    >> Share

  53. BARRA S, Providencia R
    Anticoagulation in atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-316728. doi: 10.1136/heartjnl-2020-316728
    >> Share

  54. BOYLE PM, Del Alamo JC, Akoum N
    Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models.
    Heart. 2020 Oct 23. pii: heartjnl-2020-317455. doi: 10.1136/heartjnl-2020-317455
    >> Share

    August 2020
  55. KJERPESETH LJ, Igland J, Selmer R, Ellekjaer H, et al
    Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014.
    Heart. 2020 Aug 20. pii: heartjnl-2020-316624. doi: 10.1136/heartjnl-2020-316624
    >> Share

  56. MAEDA T, Nishi T, Funakoshi S, Tada K, et al
    Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project).
    Heart. 2020 Aug 14. pii: heartjnl-2020-317299. doi: 10.1136/heartjnl-2020-317299
    >> Share

  57. HENDRIKS J, Gallagher C, Nyfort-Hansen K, Lau D, et al
    Adherence to anticoagulation therapy in patients with atrial fibrillation: is a tailored team-based approach warranted?
    Heart. 2020 Aug 7. pii: heartjnl-2020-317478. doi: 10.1136/heartjnl-2020-317478.
    >> Share

    July 2020
  58. DING WY, Gupta D, Lip GYH
    Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Heart. 2020 Jul 16. pii: heartjnl-2020-316977. doi: 10.1136/heartjnl-2020-316977
    >> Share

  59. LYCKHAGE LF, Hansen ML, Toft JC, Larsen SL, et al
    Continuous electrocardiography for detecting atrial fibrillation beyond 1 year after stroke in primary care.
    Heart. 2020 Jul 3. pii: heartjnl-2020-316904. doi: 10.1136/heartjnl-2020-316904.
    >> Share

    May 2020
  60. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726
    >> Share

  61. BURDEN AF
    Tub bathing and heart disease.
    Heart. 2020;106:710.
    >> Share

    April 2020
  62. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    >> Share

  63. CHATEAUNEUF G, Nazif TM, Beaupre F, Kodali S, et al
    Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316331. doi: 10.1136/heartjnl-2019-316331
    >> Share

  64. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    >> Share

    March 2020
  65. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    >> Share

  66. UKAI T, Iso H, Yamagishi K, Saito I, et al
    Habitual tub bathing and risks of incident coronary heart disease and stroke.
    Heart. 2020 Mar 24. pii: heartjnl-2019-315752. doi: 10.1136/heartjnl-2019-315752
    >> Share

  67. YAO X, Noseworthy P
    NOAC dosing and monitoring: really as simple as it seems?
    Heart. 2020;106:321-322.
    >> Share

    February 2020
  68. KIM JY, Kim SH, Myong JP, Choi Y, et al
    Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
    Heart. 2020 Feb 6. pii: heartjnl-2019-315883. doi: 10.1136/heartjnl-2019-315883.
    >> Share

    January 2020
  69. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957
    >> Share

  70. LU J, Zhang L, Lu Y, Su M, et al
    Secondary prevention of cardiovascular disease in China.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315884. doi: 10.1136/heartjnl-2019-315884
    >> Share

  71. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    >> Share

    November 2019
  72. CHRISTERSSON C, James SK, Lindhagen L, Ahlsson A, et al
    Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
    Heart. 2019 Nov 22. pii: heartjnl-2019-315453. doi: 10.1136/heartjnl-2019-315453
    >> Share

    October 2019
  73. YU CW
    Does thrombectomy inhibit effect of ischaemic postconditioning in STEMI? True or not?
    Heart. 2019 Oct 14. pii: heartjnl-2019-315389. doi: 10.1136/heartjnl-2019-315389
    >> Share

  74. BANERJEE A, Benedetto V, Gichuru P, Burnell J, et al
    Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
    Heart. 2019 Oct 10. pii: heartjnl-2019-315307. doi: 10.1136/heartjnl-2019-315307
    >> Share

  75. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    >> Share

    September 2019
  76. WU VC, Wu M, Aboyans V, Chang SH, et al
    Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation.
    Heart. 2019 Sep 26. pii: heartjnl-2019-315065. doi: 10.1136/heartjnl-2019-315065
    >> Share

  77. JAME S, Barnes G
    Stroke and thromboembolism prevention in atrial fibrillation.
    Heart. 2019 Sep 18. pii: heartjnl-2019-314898. doi: 10.1136/heartjnl-2019-314898
    >> Share

    August 2019
  78. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    >> Share

    June 2019
  79. MALIK AH, Yandrapalli S, Aronow WS, Panza JA, et al
    Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.
    Heart. 2019 Jun 14. pii: heartjnl-2019-314767. doi: 10.1136/heartjnl-2019-314767
    >> Share

    May 2019
  80. LINDHOLM D, Sarno G, Erlinge D, Svennblad B, et al
    Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction.
    Heart. 2019 May 4. pii: heartjnl-2018-314590. doi: 10.1136/heartjnl-2018-314590.
    >> Share

    April 2019
  81. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    >> Share

    March 2019
  82. POKORNEY SD, Lopes RD
    Atrial fibrillation: what do we know about screening and what do we not know about treatment?
    Heart. 2019 Mar 21. pii: heartjnl-2018-314518. doi: 10.1136/heartjnl-2018-314518
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016